DarioHealth (DRIO)
Combines connected devices, software, and coaching for chronic-condition care.
$6.86
vs last close−0.03 (−0.44%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 4 | 6 | 6 | 7 | 8 | 7 | 5 | 5 | 5 | 6 | 5 |
| Cost of revenue | 3 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 |
| Gross profit | 1 | 1 | 2 | 4 | 5 | 5 | 4 | 3 | 3 | 2 | 3 | 3 |
| −15 | −13 | −15 | −12 | −7 | −6 | −6 | −6 | 12 | 48 | 11 | 10 | |
| Research & development | 6 | 4 | 7 | 7 | 5 | 5 | 4 | 4 | 3 | 3 | 2 | 2 |
| 10 | 10 | 14 | 12 | 10 | 10 | 9 | 8 | 9 | 9 | 8 | 8 | |
| Selling & marketing | 6 | 5 | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 5 | 5 | 5 |
| General & administrative | 4 | 5 | 7 | 5 | 4 | 4 | 3 | 3 | 5 | 4 | 3 | 3 |
| Other expenses | −31 | −27 | −36 | −31 | −23 | −21 | −19 | −18 | 0 | 37 | 0 | 0 |
| Operating income | 16 | 14 | 18 | 16 | 12 | 12 | 9 | 9 | −9 | −46 | −7 | −6 |
| −31 | −28 | −27 | −30 | −24 | −21 | −19 | −22 | −1 | 140 | −1 | −1 | |
| Interest income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 |
| Other non-operating income | 31 | 28 | 36 | 32 | 24 | 23 | 19 | 18 | 0 | −37 | 0 | 0 |
| Income before tax | −16 | −14 | −9 | −14 | −12 | −9 | −9 | −13 | −10 | 94 | −8 | −8 |
| Income tax expense | 0 | 0 | −2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −16 | −14 | −7 | −14 | −12 | −10 | −9 | −13 | −10 | 94 | −8 | −8 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | −8 | 0 | 0 |
| Net income | −16 | −14 | −7 | −14 | −12 | −10 | −9 | −13 | −2 | 86 | −8 | −8 |
| EPS, basic | −$0.49 | −$0.44 | −$0.20 | −$0.08 | −$0.25 | −$0.26 | −$0.31 | −$0.20 | −$0.19 | $1.90 | −$0.17 | −$0.85 |
| EPS, diluted | −$0.49 | −$0.44 | −$0.20 | −$0.08 | −$0.25 | −$0.26 | −$0.31 | −$0.20 | −$0.19 | $1.90 | −$0.17 | −$0.85 |
| Weighted average shares, basic | 29 | 27 | 34 | 40 | 40 | 40 | 45 | 50 | 50 | 50 | 50 | 9 |
| Weighted average shares, diluted | 29 | 27 | 34 | 40 | 40 | 40 | 45 | 50 | 50 | 50 | 50 | 9 |
| EBITDA | −14 | −13 | −17 | −14 | −10 | −8 | −8 | −8 | −9 | −9 | −7 | −6 |
| Depreciation & amortization | 1 | 1 | 1 | 2 | 2 | 3 | 1 | 1 | 1 | 0 | 1 | 1 |
| EBIT | −16 | −14 | −18 | −16 | −12 | −11 | −9 | −9 | −9 | −9 | −7 | −6 |
